Prominent Salk Institute Scientist Inder Verma Resigns

His decision came as an investigation into sexual harassment allegations against him was ongoing.

Written bySukanya Charuchandra
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The Salk Institute of Biological StudiesISTOCK, DOUGBERRYInder Verma, a leading cancer researcher at the Salk Institute for Biological Studies, resigned on June 6 during an investigation into sexual harassment allegations against him, reports Science. In a letter on June 11, Dan Lewis, the chair of the Board of Trustees and Rusty Gage, the president of the Institute, say the Board unanimously accepted Verma’s “unconditional resignation,” calling it an “appropriate responsive action,” without offering any specifics of the investigation.

According to Science, Salk hired The Rose Group, a law firm, to investigate the case against Verma in March. Following Science’s April reporting of sexual misconduct allegations by eight women with connections to the institute, Verma was placed on administrative leave. This was in addition to his suspension as PNAS’s editor-in-chief after a gender discrimination lawsuit was filed against the Salk Institute.

Verma claims he has never misbehaved, reports The San Diego Union-Tribune. In an email to the newspaper in April, he said, “I have never used my position at the Salk Institute to take advantage of others.” He went on to add, “I have also never engaged in any sort of intimate relationship with anyone affiliated with the Salk Institute.”

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies